
Reducing Immunogenicity of Pegloticase (RECIPE) with Concomitant Use of Mycophenolate Mofetil in Patients with Refractory Gout—a Phase II Double Blind Randomized Controlled Trial

We are pleased to invite you to explore The Rheumatologist’s 2020 coverage of rheumatoid arthritis or systemic lupus erythematosus or gout sessions at ACR Convergence 2020, plus our collection of research reviews, case reports, and clinical articles on advances in the diagnosis and management of rheumatoid arthritis or systemic lupus erythematosus or gout.
• By Puja Khanna, Dinesh Khanna, Gary Cutter, Jeffrey Foster, Joshua Melnick, Sara Jaafar, Stephanie Biggers, AKM Rahman, Hui-Chen Kuo, Michelle Feese and Kenneth Saag
• By Keri Losavio
• By Jason Liebowitz, MD
• By Kurt Ullman
• By Larry Beresford
• By Susan Bernstein, with John FitzGerald, MD, PhD
• By Elizabeth Hofheinz, MPH, MEd
• By Lara C. Pullen, PhD
• By Arthritis & Rheumatology
Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.
The Foundation is the largest private funding source for rheumatology research and training in the U.S.
Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.